Physician

Anuradha R Thummala, MD

According to 2025 Medicare claims, Anuradha Thummala, MD (NPI: 1376552745) practices hematology/oncology in the Las Vegas-Henderson-North Las Vegas, NV market, with the plurality of this provider's patient population coming from Clark, NV. This provider's primary affiliated billing organization is ALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC (NPI: 1598770471; TIN: 88-0350180) and primary practice location at 89128-9011.

Thummala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,330 traditional Medicare patients, billed 472,423 HCPCS/CPT codes, and received $6,012,639 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,654 prescription claims across 393 beneficiaries totaling $6,458,872 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 12 claims. Open Payments data shows 126 records totaling $85,681. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $3,544,519 to $6,012,639. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,348,739 to $6,458,872. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.0M$6.0M2015 Medicare payment: $3,544,519 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,141,891 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,138,236 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,295,749 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,501,920 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,912,457 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,504,646 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,499,665 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,144,655 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $6,012,639 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,104390,110$3,544,519
20161,241541,858$4,141,891
20171,202468,004$4,138,236
20181,217457,373$4,295,749
20191,230454,751$4,501,920
20201,333542,538$5,912,457
20211,172478,879$4,504,646
20221,391390,585$4,499,665
20231,269452,233$5,144,655
20241,330472,423$6,012,639

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.2M$6.5M2015 Drug cost: $1,348,739 (USD; Tot_Drug_Cst)2016 Drug cost: $1,626,328 (USD; Tot_Drug_Cst)2017 Drug cost: $2,670,174 (USD; Tot_Drug_Cst)2018 Drug cost: $3,358,013 (USD; Tot_Drug_Cst)2019 Drug cost: $4,780,134 (USD; Tot_Drug_Cst)2020 Drug cost: $4,959,991 (USD; Tot_Drug_Cst)2021 Drug cost: $4,788,426 (USD; Tot_Drug_Cst)2022 Drug cost: $5,642,638 (USD; Tot_Drug_Cst)2023 Drug cost: $4,934,445 (USD; Tot_Drug_Cst)2024 Drug cost: $6,458,872 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152771,907$1,348,739
20162682,038$1,626,328
20173292,307$2,670,174
20183512,337$3,358,013
20193022,303$4,780,134
20203342,253$4,959,991
20213642,313$4,788,426
20223582,211$5,642,638
20233792,385$4,934,445
20243932,654$6,458,872

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$4.6K$9.3K2015 Medicare payment: $9,258 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $6,699 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $5,641 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $3,098 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,639 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $209 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $587 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201512123$9,258
2016N/R76$6,699
2017N/RN/RN/R
2018N/R34$5,641
2019N/R13$3,098
2020N/RN/RN/R
2021N/R42$3,639
2022N/R11$209
2023N/RN/RN/R
2024N/R12$587

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5761,282$99
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's6521,471$13
80053Blood test, comprehensive group of blood chemicals5501,612$10
36415Insertion of needle into vein for collection of blood sample5832,020$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count5882,321$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PomalystPomalidomide451,141$916,548
LenalidomideLenalidomide601,610$802,299
BrukinsaZanubrutinib521,560$718,177
RevlimidLenalidomide36882$583,228
IbrancePalbociclib31868$485,904

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0656Segmental pneumatic appliance for use with pneumatic compressor, trunkYN/R12$587

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.120$6,748Daiichi Sankyo Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.6$78,934AstraZeneca Pharmaceuticals LP
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anuradha R. Thummala, MD?

Tedicare shows public-source Medicare data for Anuradha R. Thummala, MD (NPI 1376552745), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anuradha R. Thummala, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anuradha R. Thummala, MD?

Anuradha R. Thummala, MD is linked to ALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC (billing NPI 1598770471) in the available physician profile data.

Does Anuradha R. Thummala, MD have Open Payments data?

Anuradha R. Thummala, MD has 126 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.